News | November 12, 2025
JB Pharma Q2 PAT up 19 % at Rs. 208 Cr
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Cupid has been allocated approximately 23.4 million units of female condoms per year
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
The projected business potential is around US$ 1 million in the first year
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Revenue increased 11.4 per cent to Rs. 8,545 crore
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Subscribe To Our Newsletter & Stay Updated
